Katalin Paréj

The control of the complement lectin pathway activation revisited: Both C1-inhibitor and antithrombin are likely physiological inhibitors, while α2-macroglobulin is not

Katalin Paréj, József Dobó, Péter Závodszky et al. · Molecular Immunology · 2013 · 75 citations

Medicine, Hematology, Immunology +13

Placental Galectins Are Key Players in Regulating the Maternal Adaptive Immune Response

Andrea Balogh, Eszter Tóth, Roberto Romero et al. · Frontiers in Immunology · 2019 · 66 citations · Full text

Life Sciences, Immunology, Obstetrics +17

CR3 is the dominant phagocytotic complement receptor on human dendritic cells

Noémi Sándor, Katalin Paréj, Domonkos Pap et al. · Immunobiology · 2012 · 43 citations

Life Sciences, Cell Biology, Immunology +15

Cutting Edge: A New Player in the Alternative Complement Pathway, MASP-1 Is Essential for LPS-Induced, but Not for Zymosan-Induced, Alternative Pathway Activation

Katalin Paréj, Andrea Kocsis, Csenge Enyingi et al. · The Journal of Immunology · 2018 · 23 citations · Full text

Life Sciences, Immunology, Pathobiology +13

Dissociation and re-association studies on the interaction domains of mannan-binding lectin (MBL)-associated serine proteases, MASP-1 and MASP-2, provide evidence for heterodimer formation

Katalin Paréj, Agnes Hermann, Nóra Donáth et al. · Molecular Immunology · 2014 · 20 citations

Life Sciences, Biochemistry, Molecular Biology +16